Kabra Drugs Limited (BOM:524322)

Kabra Drugs Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	212.99	26.71	0.03	0.01	0.1
Short-Term Investments	-	0.44	0.44	-	-	-
Cash & Short-Term Investments	116.99	213.43	27.15	0.03	0.01	0.1
Cash Growth	460.19%	686.23%	91932.82%	133.67%	-87.10%	-10.75%
Accounts Receivable	-	6.01	6.01	6	6	12.55
Receivables	-	6.01	6.01	6.44	6.72	13.26
Other Current Assets	-	32.19	12.33	0.33	0.33	0.33
Total Current Assets	-	251.62	45.48	6.8	7.06	13.69
Property, Plant & Equipment	-	0.44	-	-	-	0.1
Other Long-Term Assets	-	0.23	0.23	0.23	0.23	0.23
Total Assets	-	252.29	45.72	7.04	7.3	14.02
Accounts Payable	-	-	-	-	-	1.87
Short-Term Debt	-	4.37	17.09	13.82	10.26	9
Other Current Liabilities	-	1.37	17.8	0.53	0.97	5.22
Total Current Liabilities	-	5.74	34.89	14.35	11.23	16.1
Long-Term Deferred Tax Liabilities	-	0.01	-	-	-	-
Other Long-Term Liabilities	-	-	-0	0	0	-
Total Liabilities	-	5.74	34.89	14.35	11.23	16.1
Common Stock	-	237.08	43.89	43.89	43.89	43.89
Retained Earnings	-	9.47	-58.56	-51.2	-47.82	-45.96
Comprehensive Income & Other	-	-0	25.5	-	-	-
Shareholders' Equity	259.92	246.55	10.83	-7.31	-3.93	-2.08
Total Liabilities & Equity	-	252.29	45.72	7.04	7.3	14.02
Total Debt	4.69	4.37	17.09	13.82	10.26	9
Net Cash (Debt)	112.29	209.06	10.06	-13.79	-10.25	-8.91
Net Cash Growth	675.46%	1977.87%	-	-	-	-
Net Cash Per Share	5.32	19.13	2.29	-3.14	-2.33	-2.03
Filing Date Shares Outstanding	23.76	23.71	4.39	4.39	4.39	4.39
Total Common Shares Outstanding	23.76	23.71	4.39	4.39	4.39	4.39
Working Capital	-	245.88	10.6	-7.54	-4.16	-2.41
Book Value Per Share	10.90	10.40	2.47	-1.67	-0.90	-0.47
Tangible Book Value	259.89	246.55	10.83	-7.31	-3.93	-2.08
Tangible Book Value Per Share	10.89	10.40	2.47	-1.67	-0.90	-0.47
Machinery	-	0.44	-	1.66	1.66	1.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.